Partitioning of Pulmonary Vascular Resistance in Primary Pulmonary Hypertension 11This study was supported by Grant 3.4517.95 from the Fonds de la Recherche Scientifique Médicale Belgium and by the Belgian Foundation for Cardiac Surgery, Brussels. Sophia Abdel Kafi was a fellow of the Erasmus Foundation, Brussels.

This publication has 20 references indexed in Scilit:

• Site of Pulmonary Vasodilation by Inhaled Nitric Oxide in Microembolic Lung Injury
  American Journal of Respiratory and Critical Care Medicine, 1997
• Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension
  New England Journal of Medicine, 1996
• Clinical Significance of the Pulmonary Vasodilator Response During Short-term Infusion of Prostacyclin in Primary Pulmonary Hypertension
  Circulation, 1996
• Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.
  American Journal of Respiratory and Critical Care Medicine, 1995
• Derivation of pulmonary capillary pressure from arterial occlusion in intact conditions
  Critical Care Medicine, 1994
• Nature of pulmonary hypertension in congestive heart failure. Effects of cardiac transplantation.
  American Journal of Respiratory and Critical Care Medicine, 1994
• Primary pulmonary hypertension and fenfluramine use.
  Heart, 1993
• Pulmonary capillary pressure
  Critical Care Medicine, 1992
• The pressure-flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease.
  Circulation, 1985
• On pulmonary vascular resistance: The need for more precise definition
  The American Journal of Cardiology, 1985